rs3744026

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_199242.3(UNC13D):​c.1596+36A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,613,888 control chromosomes in the GnomAD database, including 21,362 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 7932 hom., cov: 33)
Exomes 𝑓: 0.094 ( 13430 hom. )

Consequence

UNC13D
NM_199242.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.92

Publications

18 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 17-75835819-T-C is Benign according to our data. Variant chr17-75835819-T-C is described in ClinVar as Benign. ClinVar VariationId is 263215.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.58 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.1596+36A>G intron_variant Intron 18 of 31 ENST00000207549.9 NP_954712.1 Q70J99-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.1596+36A>G intron_variant Intron 18 of 31 1 NM_199242.3 ENSP00000207549.3 Q70J99-1

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35095
AN:
152084
Hom.:
7907
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.586
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.132
Gnomad ASJ
AF:
0.179
Gnomad EAS
AF:
0.331
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.0531
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.0684
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.141
AC:
35467
AN:
251240
AF XY:
0.134
show subpopulations
Gnomad AFR exome
AF:
0.605
Gnomad AMR exome
AF:
0.0942
Gnomad ASJ exome
AF:
0.159
Gnomad EAS exome
AF:
0.340
Gnomad FIN exome
AF:
0.0511
Gnomad NFE exome
AF:
0.0699
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.0938
AC:
137126
AN:
1461686
Hom.:
13430
Cov.:
35
AF XY:
0.0948
AC XY:
68923
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.605
AC:
20249
AN:
33480
American (AMR)
AF:
0.0989
AC:
4425
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
4081
AN:
26136
East Asian (EAS)
AF:
0.338
AC:
13436
AN:
39700
South Asian (SAS)
AF:
0.152
AC:
13100
AN:
86258
European-Finnish (FIN)
AF:
0.0536
AC:
2851
AN:
53220
Middle Eastern (MID)
AF:
0.250
AC:
1442
AN:
5768
European-Non Finnish (NFE)
AF:
0.0626
AC:
69597
AN:
1112006
Other (OTH)
AF:
0.132
AC:
7945
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
8648
17296
25945
34593
43241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2996
5992
8988
11984
14980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.231
AC:
35163
AN:
152202
Hom.:
7932
Cov.:
33
AF XY:
0.228
AC XY:
17002
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.586
AC:
24345
AN:
41510
American (AMR)
AF:
0.131
AC:
2009
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.179
AC:
621
AN:
3470
East Asian (EAS)
AF:
0.330
AC:
1706
AN:
5164
South Asian (SAS)
AF:
0.155
AC:
751
AN:
4830
European-Finnish (FIN)
AF:
0.0531
AC:
564
AN:
10620
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.0684
AC:
4651
AN:
67988
Other (OTH)
AF:
0.205
AC:
433
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1031
2061
3092
4122
5153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.124
Hom.:
3062
Bravo
AF:
0.254
Asia WGS
AF:
0.233
AC:
809
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 18. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.23
DANN
Benign
0.25
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744026; hg19: chr17-73831900; COSMIC: COSV52883523; COSMIC: COSV52883523; API